Abstract: Some embodiments are directed to a process for quantifying changes in the intestinal mucosa caused by a chronic inflammatory intestinal disease in individuals, an ex vivo process for diagnosing a chronic inflammatory intestinal disease in individuals, and an ex vivo process for the differential diagnosis of Crohn's disease versus ulcerative colitis in individuals.
Type:
Grant
Filed:
March 15, 2017
Date of Patent:
March 7, 2023
Assignees:
UNIVERSITÉ DE NANTES, CHU DE NANTES—CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES, INSERM—INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Inventors:
Jérémy Brégeon, Michel Neunlist, Emmanuel Coron